Weil is advising Avista Healthcare Partners and its portfolio company WellSpring Consumer Healthcare in WellSpring’s acquisition of vH essentials from Wisconsin Pharmacal Company.

WellSpring is a developer and marketer of leading over-the-counter and personal care brands and a portfolio company of Avista Healthcare Partners, a leading middle-market healthcare private equity firm with expertise in building growth-oriented healthcare businesses. vH essentials offers a comprehensive portfolio of OTC products for women’s intimacy care.

The Weil team is led by Private Equity partner Brian Parness and includes Private Equity counsel Alexander Miachika and associates Luisa Perez, Anthony Tulipano and Brayden Ringel; Tax partner Helyn Goldstein and associate Josh Schonfeld; Banking & Finance partner Andrew Yoon and associates Dylan Scher and Dan Cruickshank; U.S. Privacy & Cybersecurity Head Olivia Greer; Technology & IP Transactions partner Dennis Adams and associates Shannon Coffey, Colleen Seidel and Brendan McNerney; Regulatory Transactions partner John O’Loughlin and associate Christina Carone; and Antitrust partner John Scribner and counsel Michael Naughton.